Related Experiment Video
Updated: May 16, 2026
08:28
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
[Pharmacogenetics: relevant aspects for the practicing veterinarian].
R Jud Schefer1, C Paine Kuhn, D Demuth
1Institut für Veterinärpharmakologie und -toxikologie der Universität Zürich. rjud@vetclinics.uzh.ch
Schweizer Archiv Fur Tierheilkunde
|November 29, 2012
Summary
Pharmacogenetics explores how genetic variations influence drug responses in animals. Understanding genetic mutations, like the MDR1 defect, is crucial for preventing adverse drug reactions and ensuring effective veterinary treatment.
Area of Science:
- Veterinary Pharmacology
- Genetics
- Drug Metabolism
Context:
- Genetic variations significantly impact drug efficacy and safety.
- The MDR1 mutation in certain dog breeds alters P-glycoprotein function.
- Enzyme genetic defects affect drug metabolism pathways.
Purpose:
- To highlight the role of pharmacogenetics in veterinary medicine.
- To explain how genetic mutations lead to altered drug responses.
- To underscore the importance of understanding genetic factors in drug therapy.
Summary:
- Pharmacogenetics investigates genetic influences on drug responses, including metabolic pathways, therapeutic effects, and adverse reactions.
- Common genetic defects like the MDR1 mutation in Collies alter P-glycoprotein, affecting drug transport.
- Mutations in drug-metabolizing enzymes (e.g., cytochrome P450) can result in decreased function, leading to higher drug concentrations and potential overdose.
Impact:
- Improved understanding of drug safety and efficacy in veterinary patients.
- Potential for personalized drug therapy based on an animal's genetic profile.
- Reduced incidence of adverse drug events and treatment failures in veterinary medicine.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...